Unlock

Nov 04, 2024 CrossBridge Bio Secures $10M Investment to Revolutionize Cancer Treatment with Dual-Payload ADCs. (Source) BigHat Biosciences teams up… 

Nov 04, 2024 Journey Medical’s Emrosi, a small-molecule treatment for rosacea, receives FDA approval. (Source) Viking Therapeutics announces positive Phase… 

Oct 29, 2024 Vaxinano Secures €6 Million ($6.5M) Investment to Bring Nasal Vaccines Closer to Clinical Testing. (Source) Clover’s SCB-1019… 

Oct 31, 2024 Roche’s bispecific antibody, trontinemab, demonstrates significant potential in Alzheimer’s treatment, rapidly reducing amyloid plaques in early-stage trials,… 

Oct 28, 2024 Eli Lilly’s GLP-1 drug Mounjaro receives Hong Kong approval for treating obesity and associated health problems like… 

Oct 31, 2024 Spur Therapeutics announces positive preclinical results for SBT101, its gene therapy candidate designed to treat Adrenomyeloneuropathy (AMN).… 

Oct 17, 2024 OmniaBio Opens New Commercial Manufacturing Facility in Canada for Cell and Gene Therapies. (Source) Oct 10, 2024… 

Oct 24, 2024 Tessera Releases Promising Preclinical Data for Its In Vivo Gene Editing Technology, Showcasing Potential Treatments for Alpha-1… 

Oct 30, 2024 Galapagos reports strong Q3 progress, including advancing CAR-T programs to clinical trials. Cell therapy, non-Hodgkin lymphoma, cancer…